Brief: Propanc Biopharma Pursues Strategic Acquisition of DAT Firms Trading Below Market Cap To Net Asset Value
04/11/2025 12:26
Nov 4 (Reuters) - Propanc Biopharma Inc PPCB.O: PROPANC BIOPHARMA, INC. PURSUES STRATEGIC ACQUISITION PLAN TARGETING DIGITAL ASSET TREASURY (DAT) COMPANIES TRADING BELOW MARKET CAP TO NET ASSET VALUE (MNAV) Source text: ID:nGNX4sKhrQ Further company coverage: PPCB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Propanc Biopharma
See all newsNASDAQ TRADE HALT HALT NEWS PENDING AT 09:29 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition With Prp In Pancreatic Cancer Models, Contrasting Profile With Revolution Medicines’ Daraxonrasib
Brief: Propanc Biopharma Registers Resale Of 6,500,000 Shares Of Common Stock - SEC Filing
Brief: Propanc Biopharma To File Cta In Australia For Phase 1B Study In 30–40 Advanced Cancer Patients